1-20 of 7432
Section: POSTER PRESENTATIONS
Journal Article
P0899 Previous extended colectomy is associated with particularly high risk of postoperative small bowel fistula in Crohn’s disease patients
Journal of Crohn's and Colitis, Volume 19, Issue Supplement_1, January 2025, Page i1700, https://doi.org/10.1093/ecco-jcc/jjae190.1073
Published: 22 January 2025
Journal Article
P0852 Influence of a gluten-free dietary intervention on the gut microbiome and inflammation in inflammatory bowel disease: results from murine experiments and protocol of a prospective proof-of-concept human study as part of the miGut-Health project
Journal of Crohn's and Colitis, Volume 19, Issue Supplement_1, January 2025, Page i1624, https://doi.org/10.1093/ecco-jcc/jjae190.1026
Published: 22 January 2025
Journal Article
P0836 Real-world application of the Crohn’s disease clinical decision support tool (CDST) in both intravenous and subcutaneous vedolizumab
Journal of Crohn's and Colitis, Volume 19, Issue Supplement_1, January 2025, Pages i1595–i1596, https://doi.org/10.1093/ecco-jcc/jjae190.1010
Published: 22 January 2025
Journal Article
P0696 ADSS: A novel AI-derived metric for quantifying disease severity and extent in ulcerative colitis
Journal of Crohn's and Colitis, Volume 19, Issue Supplement_1, January 2025, Pages i1360–i1361, https://doi.org/10.1093/ecco-jcc/jjae190.0870
Published: 22 January 2025
Journal Article
P0695 Quantifying the benefit-risk trade-offs adult patients and providers are willing to make when considering advanced therapies for moderate to severe Ulcerative Colitis: A discrete choice experiment
Journal of Crohn's and Colitis, Volume 19, Issue Supplement_1, January 2025, Pages i1357–i1359, https://doi.org/10.1093/ecco-jcc/jjae190.0869
Published: 22 January 2025
Journal Article
P0671 Supporting vedolizumab treatment throughout pregnancy: Insights from a population pharmacokinetic model
Journal of Crohn's and Colitis, Volume 19, Issue Supplement_1, January 2025, Pages i1313–i1315, https://doi.org/10.1093/ecco-jcc/jjae190.0845
Published: 22 January 2025
Journal Article
P0655 VTE thromboprophylaxis in patients with inflammatory bowel disease admitted to hospital; can we increase adherence with guidelines?
Journal of Crohn's and Colitis, Volume 19, Issue Supplement_1, January 2025, Page i1282, https://doi.org/10.1093/ecco-jcc/jjae190.0829
Published: 22 January 2025
Journal Article
P0955 Calcium supplementation, but not the Mediterranean diet, significantly reduced bone resorption metabolite in patients with inflammatory bowel disease (IBD): A randomized controlled trial
Journal of Crohn's and Colitis, Volume 19, Issue Supplement_1, January 2025, Page i1782, https://doi.org/10.1093/ecco-jcc/jjae190.1129
Published: 22 January 2025
Journal Article
P0795 Clinical symptoms, C-reactive protein and albumin at admission to hospital poorly correlate with refractoriness to intravenous steroids in Acute Severe Ulcerative Colitis – posthoc analysis of the IASO trial
Journal of Crohn's and Colitis, Volume 19, Issue Supplement_1, January 2025, Pages i1527–i1528, https://doi.org/10.1093/ecco-jcc/jjae190.0969
Published: 22 January 2025
Journal Article
P0757 Emulsifier restriction does not impair nutrient intake and improves food-related quality of life in active Crohn’s disease: dietary analysis of the ADDapt randomised controlled trial
Journal of Crohn's and Colitis, Volume 19, Issue Supplement_1, January 2025, Pages i1460–i1462, https://doi.org/10.1093/ecco-jcc/jjae190.0931
Published: 22 January 2025
Journal Article
P0661 Effectiveness of upadacitinib for induction of remission in moderate-to-severe ulcerative colitis: real-world clinical outcomes appear independent of prior tofacitinib exposure
Journal of Crohn's and Colitis, Volume 19, Issue Supplement_1, January 2025, Page i1293, https://doi.org/10.1093/ecco-jcc/jjae190.0835
Published: 22 January 2025
Journal Article
P0949 Long term real-world effectiveness and safety of upadacitinib in patients with moderate to severe Crohn’s disease: A Belgian multi-centric refractory cohort
Journal of Crohn's and Colitis, Volume 19, Issue Supplement_1, January 2025, Pages i1773–i1774, https://doi.org/10.1093/ecco-jcc/jjae190.1123
Published: 22 January 2025
Journal Article
P0946 Switching from intravenous to subcutaneous Infliximab in patients with immune mediated diseases in clinical remission
Journal of Crohn's and Colitis, Volume 19, Issue Supplement_1, January 2025, Page i1770, https://doi.org/10.1093/ecco-jcc/jjae190.1120
Published: 22 January 2025
Journal Article
P0697 Ozanimod Inhibits Pro-Inflammatory Mediators of the IL-17 Pathway in the Tissues of Participants in the Phase 2 TOUCHSTONE Study
Journal of Crohn's and Colitis, Volume 19, Issue Supplement_1, January 2025, Page i1362, https://doi.org/10.1093/ecco-jcc/jjae190.0871
Published: 22 January 2025
Journal Article
P0677 Population-Based Analysis of 30-Day Postoperative Course in Crohn’s Disease Patients Undergoing Primary Bowel Resection
Journal of Crohn's and Colitis, Volume 19, Issue Supplement_1, January 2025, Page i1326, https://doi.org/10.1093/ecco-jcc/jjae190.0851
Published: 22 January 2025
Journal Article
P0926 The impact of anti-integrin αvβ6 antibody positivity on clinical characteristics and treatment outcomes with biological agents in pediatric IBD: a single-center retrospective study
Journal of Crohn's and Colitis, Volume 19, Issue Supplement_1, January 2025, Page i1739, https://doi.org/10.1093/ecco-jcc/jjae190.1100
Published: 22 January 2025
Journal Article
P0898 Comparative Study on the Efficacy of Biologics with Dietary Intervention in Crohn's Disease: Evaluating the Impact of Crohn's Disease Exclusion Diet and partial Entral nutrition Combination with Biologics
Journal of Crohn's and Colitis, Volume 19, Issue Supplement_1, January 2025, Pages i1698–i1699, https://doi.org/10.1093/ecco-jcc/jjae190.1072
Published: 22 January 2025
Journal Article
P0896 A double-blind, randomized, placebo-controlled, single-center, pilot study evaluating the efficacy of a synbiotic formulation in modulating gut microbiota biodiversity in patients with mild-to-moderate UC in clinical and endoscopic remission
Journal of Crohn's and Colitis, Volume 19, Issue Supplement_1, January 2025, Page i1696, https://doi.org/10.1093/ecco-jcc/jjae190.1070
Published: 22 January 2025
Journal Article
P0829 ‘Temporary’ faecal diversion in refractory Crohn’s Disease: too good to be true? A retrospective, single centre analysis
Journal of Crohn's and Colitis, Volume 19, Issue Supplement_1, January 2025, Page i1581, https://doi.org/10.1093/ecco-jcc/jjae190.1003
Published: 22 January 2025
Journal Article
P0826 Switching to standard-dose subcutaneous vedolizumab increases the percentage of patients in biochemical remission even in those intensified with intravenous vedolizumab: one year results of a Spanish multicentre observational study
Journal of Crohn's and Colitis, Volume 19, Issue Supplement_1, January 2025, Pages i1576–i1577, https://doi.org/10.1093/ecco-jcc/jjae190.1000
Published: 22 January 2025
